Cargando…

Research Progress Concerning a Novel Intraocular Lens for the Prevention of Posterior Capsular Opacification

Posterior capsular opacification (PCO) is the most common complication resulting from cataract surgery and limits the long-term postoperative visual outcome. Using Nd:YAG laser-assisted posterior capsulotomy for the clinical treatment of symptomatic PCO increases the risks of complications, such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yidong, Zhang, Chengshou, Chen, Silong, Hu, Jianghua, Shen, Lifang, Yu, Yibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318653/
https://www.ncbi.nlm.nih.gov/pubmed/35890240
http://dx.doi.org/10.3390/pharmaceutics14071343
_version_ 1784755346216058880
author Zhang, Yidong
Zhang, Chengshou
Chen, Silong
Hu, Jianghua
Shen, Lifang
Yu, Yibo
author_facet Zhang, Yidong
Zhang, Chengshou
Chen, Silong
Hu, Jianghua
Shen, Lifang
Yu, Yibo
author_sort Zhang, Yidong
collection PubMed
description Posterior capsular opacification (PCO) is the most common complication resulting from cataract surgery and limits the long-term postoperative visual outcome. Using Nd:YAG laser-assisted posterior capsulotomy for the clinical treatment of symptomatic PCO increases the risks of complications, such as glaucoma, retinal diseases, uveitis, and intraocular lens (IOL) pitting. Therefore, finding how to prevent PCO development is the subject of active investigations. As a replacement organ, the IOL is implanted into the lens capsule after cataract surgery, but it is also associated with the occurrence of PCO. Using IOL as a medium for PCO prophylaxis is a more facile and efficient method that has demonstrated various clinical application prospects. Thus, scientists have conducted a lot of research on new intraocular lens fabrication methods, such as optimizing IOL materials and design, and IOL surface modification (including plasma/ultraviolet/ozone treatment, chemical grafting, drug loading, coating modification, and layer-by-layer self-assembly methods). This paper summarizes the research progress for different types of intraocular lenses prepared by different surface modifications, including anti-biofouling IOLs, enhanced-adhesion IOLs, micro-patterned IOLs, photothermal IOLs, photodynamic IOLs, and drug-loading IOLs. These modified intraocular lenses inhibit PCO development by reducing the residual intraoperative lens epithelial cells or by regulating the cellular behavior of lens epithelial cells. In the future, more works are needed to improve the biosecurity and therapeutic efficacy of these modified IOLs.
format Online
Article
Text
id pubmed-9318653
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93186532022-07-27 Research Progress Concerning a Novel Intraocular Lens for the Prevention of Posterior Capsular Opacification Zhang, Yidong Zhang, Chengshou Chen, Silong Hu, Jianghua Shen, Lifang Yu, Yibo Pharmaceutics Review Posterior capsular opacification (PCO) is the most common complication resulting from cataract surgery and limits the long-term postoperative visual outcome. Using Nd:YAG laser-assisted posterior capsulotomy for the clinical treatment of symptomatic PCO increases the risks of complications, such as glaucoma, retinal diseases, uveitis, and intraocular lens (IOL) pitting. Therefore, finding how to prevent PCO development is the subject of active investigations. As a replacement organ, the IOL is implanted into the lens capsule after cataract surgery, but it is also associated with the occurrence of PCO. Using IOL as a medium for PCO prophylaxis is a more facile and efficient method that has demonstrated various clinical application prospects. Thus, scientists have conducted a lot of research on new intraocular lens fabrication methods, such as optimizing IOL materials and design, and IOL surface modification (including plasma/ultraviolet/ozone treatment, chemical grafting, drug loading, coating modification, and layer-by-layer self-assembly methods). This paper summarizes the research progress for different types of intraocular lenses prepared by different surface modifications, including anti-biofouling IOLs, enhanced-adhesion IOLs, micro-patterned IOLs, photothermal IOLs, photodynamic IOLs, and drug-loading IOLs. These modified intraocular lenses inhibit PCO development by reducing the residual intraoperative lens epithelial cells or by regulating the cellular behavior of lens epithelial cells. In the future, more works are needed to improve the biosecurity and therapeutic efficacy of these modified IOLs. MDPI 2022-06-25 /pmc/articles/PMC9318653/ /pubmed/35890240 http://dx.doi.org/10.3390/pharmaceutics14071343 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Zhang, Yidong
Zhang, Chengshou
Chen, Silong
Hu, Jianghua
Shen, Lifang
Yu, Yibo
Research Progress Concerning a Novel Intraocular Lens for the Prevention of Posterior Capsular Opacification
title Research Progress Concerning a Novel Intraocular Lens for the Prevention of Posterior Capsular Opacification
title_full Research Progress Concerning a Novel Intraocular Lens for the Prevention of Posterior Capsular Opacification
title_fullStr Research Progress Concerning a Novel Intraocular Lens for the Prevention of Posterior Capsular Opacification
title_full_unstemmed Research Progress Concerning a Novel Intraocular Lens for the Prevention of Posterior Capsular Opacification
title_short Research Progress Concerning a Novel Intraocular Lens for the Prevention of Posterior Capsular Opacification
title_sort research progress concerning a novel intraocular lens for the prevention of posterior capsular opacification
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318653/
https://www.ncbi.nlm.nih.gov/pubmed/35890240
http://dx.doi.org/10.3390/pharmaceutics14071343
work_keys_str_mv AT zhangyidong researchprogressconcerninganovelintraocularlensforthepreventionofposteriorcapsularopacification
AT zhangchengshou researchprogressconcerninganovelintraocularlensforthepreventionofposteriorcapsularopacification
AT chensilong researchprogressconcerninganovelintraocularlensforthepreventionofposteriorcapsularopacification
AT hujianghua researchprogressconcerninganovelintraocularlensforthepreventionofposteriorcapsularopacification
AT shenlifang researchprogressconcerninganovelintraocularlensforthepreventionofposteriorcapsularopacification
AT yuyibo researchprogressconcerninganovelintraocularlensforthepreventionofposteriorcapsularopacification